This week, we will discuss The ADVOR trial, possibly the only randomized, placebo controlled trial of sequential nephron blockade ever. Could the use of acetazolamide in acute decompensated heart failure make a difference?
Nominations are now open for the 2022 NephJC Kidneys
Vancomycin and Piperacillin-Tazobactam: Friends or foes?
Vancomycin/Pip-Taz associated AKI - The Visual Abstract
Is Vancomycin/Piperacillin-tazobactam combination associated with higher rates of AKI?
Adeyemo Abiodun explains it beautifully with his visual abstract
And luckily this chat has another wonderful visual abstract by PS Vali.
Chronicles of Chronotherapy in Controlling Cardiovascular Complications
A scientist teases The Codebreaker
The NephJC Summer Book Club: 'Codebreaker'
Speak volumes: #TenTweetNephJC wrap-up on CLASSIC
Intravenous fluids in sepsis - not exactly a rare treatment in a niche condition. Rapidly catch-up on this weeks journal club at the link for the take-home points.
Is Less Always More? The Case of Fluids in Septic Shock
The CLASSIC Visual Abstract
SODIUM-HF: removing 'strict' from 'restriction'
If you missed out of the great #NephJC chat this week you can catch-up with our rapid 10 tweet summary.
The Sodium HF Visual Abstract
Sodium HF: Control-Salt-Delete
Antibiotics and sudden cardiac death: #NephJC Tweetorial Catch-up
Which antibiotics increase risk of sudden death in your patient on haemodialysis? Probably something you should know. Check out our rapid-fire summary tweetorial at the link!
Azithromycin and arrythmias: The Visual Abstract
Arrhythmias with Antibiotics
PATH-BP in Kidney Medicine
The #NephJC editorial on PATH-BP is now live on Kidney Medicine!
Nice work by Momen Abbasi, Priya John, Cristina Popa, helmed by Jade and Jamie.
What is dd-cfDNA and how might it help?
Read the #TenTweetNephJC summary of the ADMIRAL study, examining how dd-cfDNA monitoring may help us manage our patients with renal transplants.
